izpis_h1_title_alt

High-sensitivity C-reactive protein and carotid intima media thickness as markers of subclinical inflammation and atherosclerosis in pediatric patients with hypercholesterolemia
ID Blinc, Lana (Author), ID Mlinarič, Matej (Author), ID Battelino, Tadej (Author), ID Grošelj, Urh (Author)

.pdfPDF - Presentation file, Download (249,60 KB)
MD5: 733F9C4BCB775D00BF4F1E38B8322ACD
URLURL - Source URL, Visit https://www.mdpi.com/1420-3049/25/21/5118 This link opens in a new window

Abstract
Hypercholesterolemia is a major cause of atherosclerosis development and premature cardiovascular disease (CVD). It leads to inflammation, which further accelerates atherosclerosis progression. Familial hypercholesterolemia (FH) is an autosomal dominant disorder characterized by elevated serum LDL-c from birth, due to a disease-causing variant in one of the causative genes (LDLR, APOB, PCSK9). In polygenic hypercholesterolemia (PH), the disease-causing genetic variant is absent; it is likely the cumulative result of multiple single nucleotide polymorphisms in LDL metabolism-related genes and other factors, such as lifestyle and environment. In high risk groups, such as patients with FH, an effective primary prevention of CVD must begin in childhood. High-sensitivity C-reactive protein (hsCRP) and carotid intima media thickness (cIMT) are two potential minimally invasive correlates of inflammation and subclinical atherosclerosis progression. hsCRP and cIMT have been shown to be significantly increased in patients with FH and PH relative to healthy controls, with some studies yielding conflicting results. In this review, we aim to summarize current knowledge and recent findings regarding the applicability of hsCRP and cIMT as markers of low-grade inflammation and subclinical atherosclerosis, focusing especially on children and adolescents with hypercholesterolemia.

Language:English
Keywords:familial hypercholesterolemia, polygenic hypercholesterolemia, inflammation, atherosclerosis, carotid intima media thickness, cIMT, C-reactive protein, hsCRP
Work type:Article
Typology:1.02 - Review Article
Organization:MF - Faculty of Medicine
Publication status:Published
Publication version:Version of Record
Year:2020
Number of pages:14 str.
Numbering:Vol. 25, iss. 21, art. 5118
PID:20.500.12556/RUL-134722 This link opens in a new window
UDC:616.053.2
ISSN on article:1420-3049
DOI:10.3390/molecules25215118 This link opens in a new window
COBISS.SI-ID:37628419 This link opens in a new window
Publication date in RUL:27.01.2022
Views:603
Downloads:123
Metadata:XML RDF-CHPDL DC-XML DC-RDF
:
Copy citation
Share:Bookmark and Share

Record is a part of a journal

Title:Molecules
Shortened title:Molecules
Publisher:MDPI
ISSN:1420-3049
COBISS.SI-ID:18462981 This link opens in a new window

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.
Licensing start date:04.11.2020

Projects

Funder:ARRS - Slovenian Research Agency
Project number:J3-2356
Name:Izražanje in funkcionalna analiza nekodirajočih RNA pri parkinsonovi bolezni

Funder:ARRS - Slovenian Research Agency
Project number:P3-0343
Name:Etiologija, zgodnje odkrivanje in zdravljenje bolezni pri otrocih in mladostnikih

Similar documents

Similar works from RUL:
Similar works from other Slovenian collections:

Back